Solopharm
Solopharm (Grotex OOO) – Russian pharmaceutical company, which produces liquid sterile dosage forms according to GMP standards (license № 00023-LS).[1] Product line consists of infusion and injection solutions, ophthalmic, otolaryngological, gastroenterological, rheumatological and cosmetological products.
History[edit]
Solopharm company was established in 2010.[2] The owner and director of Solopharm company is Russian businessman Oleg Zherebtsov. In August 2014 – launch of injection and infusion solution lines by the innovative technology Blow-Fill-Seal accepted in the world as the most perfect technology for production of sterile solutions with opportunity to use aseptic filling or finish sterilization.[3] Solopharm company continues building and assembling new lines to increase the amount of liquid medicines in ophthalmology, otolaryngology, gastroenterology, rheumatology and cosmetology.[4]
Activity[edit]
The company activity is directed to development and production of:
- Products in polyethylene and polypropylene packaging
- Generics in different therapeutic areas
- Own brands of drugs and medical products
Product Lines[edit]
- Ophthalmology
- Rheumatology
- Otolaryngology
- Pulmonology
- Cosmetology
- Gastroenterology
- Injection solutions
- Infusion solutions
References[edit]
- ^ "Фармзавод Solopharm инвестирует 32 млн евро в строительство третьей очереди". Фармацевтический вестник. 2015-09-22. Archived from the original on 2016-03-05. Retrieved 2016-04-18.
- ^ Елена Кром, Наталья Доброва (2015-05-15). "О.Жеребцов: от продуктового ретейла до производства вакцин". РБК. Archived from the original on 2016-03-05. Retrieved 2016-04-16.
- ^ Богдан Боколейко (2015-10-05). "Первая конференция компании Solopharm для СМИ. Репортаж канала Санкт-Петербург". Бизнес Петербург. Archived from the original on 2016-03-05. Retrieved 2016-04-18.
- ^ "Два инвестиционных проекта получили статус стратегических". Новотека. 2016-01-11. Archived from the original on 2016-03-05. Retrieved 2016-04-18.